Literature DB >> 17292514

West Nile virus: recent trends in diagnosis and vaccine development.

G Dauphin1, S Zientara.   

Abstract

West Nile virus (WNV) is a mosquito-borne flavivirus, native to Africa, Europe, and Western Asia. In many respects, WNV is an outstanding example of a zoonotic pathogen that has leaped geographical barriers and can cause severe disease in human and horse. Before the emergence of WNV in the USA, only few methods of diagnosis were available. Recently, many changes in the fields of WN diagnosis and prevention have happened. This paper will review all these new tools. After a description of the main concerns in WNV and West Nile (WN) disease in humans and animals, this review will present the main available tests for serology and virology detection, from gold standard tests to more recently developed methods. Finally, licensed vaccines and candidate vaccines developed in humans, horses and birds will also been described.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17292514     DOI: 10.1016/j.vaccine.2006.12.005

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  49 in total

1.  Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.

Authors:  Orly Gershoni-Yahalom; Shimon Landes; Smadar Kleiman-Shoval; David Ben-Nathan; Michal Kam; Bat-El Lachmi; Yevgeny Khinich; Michael Simanov; Itzhak Samina; Anat Eitan; Irun R Cohen; Bracha Rager-Zisman; Angel Porgador
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

Review 2.  West Nile virus: A re-emerging pathogen revisited.

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2012-04-12

3.  High seroprevelance of West Nile virus antibodies observed in horses from southwestern Nigeria.

Authors:  Waidi Folorunso Sule; Daniel Oladimeji Oluwayelu; Rahamon Akinyele Moshood Adedokun; Nurudeen Rufai; Fiona McCracken; Karen L Mansfield; Nicholas Johnson
Journal:  Vector Borne Zoonotic Dis       Date:  2015-03       Impact factor: 2.133

4.  A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

Authors:  Nathalie Bonafé; Joseph A Rininger; Richard G Chubet; Harald G Foellmer; Stacey Fader; John F Anderson; Sandra L Bushmich; Karen Anthony; Michel Ledizet; Erol Fikrig; Raymond A Koski; Paul Kaplan
Journal:  Vaccine       Date:  2008-11-07       Impact factor: 3.641

5.  West nile virus: characteristics of an african virus adapting to the third millennium world.

Authors:  Marina Monini; Emiliana Falcone; Luca Busani; Roberto Romi; Franco Maria Ruggeri
Journal:  Open Virol J       Date:  2010-04-22

6.  Bioinformatics in new generation flavivirus vaccines.

Authors:  Penelope Koraka; Byron E E Martina; Albert D M E Osterhaus
Journal:  J Biomed Biotechnol       Date:  2010-05-10

7.  Epitope-blocking enzyme-linked immunosorbent assay to differentiate west nile virus from Japanese encephalitis virus infections in equine sera.

Authors:  Yoko Kitai; Mizue Shoda; Takashi Kondo; Eiji Konishi
Journal:  Clin Vaccine Immunol       Date:  2007-06-27

8.  Complete genome analysis and virulence characteristics of the Louisiana West Nile virus strain LSU-AR01.

Authors:  Arun V Iyer; Marc J Boudreaux; Nobuko Wakamatsu; Alma F Roy; Abolghasem Baghian; Vladimir N Chouljenko; Konstantin G Kousoulas
Journal:  Virus Genes       Date:  2009-01-08       Impact factor: 2.332

9.  Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa.

Authors:  Marietjie Venter; Stacey Human; Dewald Zaayman; Gertruida H Gerdes; June Williams; Johan Steyl; Patricia A Leman; Janusz Tadeusz Paweska; Hildegard Setzkorn; Gavin Rous; Sue Murray; Rissa Parker; Cynthia Donnellan; Robert Swanepoel
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

10.  In vitro analysis of expression vectors for DNA vaccination of horses: the effect of a Kozak sequence.

Authors:  Gudbjörg Olafsdóttir; Vilhjálmur Svansson; Sigurdur Ingvarsson; Eliane Marti; Sigurbjörg Torsteinsdóttir
Journal:  Acta Vet Scand       Date:  2008-11-04       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.